Eliminate high‑price, low‑quality, and slow‑delivery headaches with a single partner that delivers high‑purity mitochondrial peptides on your schedule.
Corporate Purchasing Managers and Technical Directors in the USA are facing a perfect storm of price inflation, quality uncertainty, and logistical bottlenecks. Below are the three most common pain points that stall R&D timelines and inflate budgets.
According to a 2025 industry survey, 37% of biotech firms postponed clinical‑stage projects because of peptide supply issues. Imagine the opportunity cost of a delayed trial—lost market share, delayed revenue, and strained investor confidence.
Discover how Global Technology Co., Ltd eliminates these risks.
Global Technology Co., Ltd combines a powerful factory network with strict GMP, DMF, and FDA‑compliant processes to deliver custom mitochondrial peptides that meet the highest pharmaceutical standards.
| Parameter | Typical Value | Unit |
|---|---|---|
| Purity (HPLC) | ≥ 98.5 | % |
| Sequence Length | 5–50 | aa |
| Scale Range | 10 mg – 5 kg | Batch |
| Delivery Lead Time | 7 days (≤10 g) – 15 days (≥1 kg) | Days |
| Shipping Options | DHL, FedEx, UPS, Sea‑Freight | — |
Scenario 1 – Pre‑clinical Mitochondrial Dysfunction Model
A US‑based biotech needed a mitochondria‑targeted peptide (MTP‑001) for a mouse model. We delivered 2 g of 99% pure peptide within 9 days, cutting their development timeline by 30% and saving $18 K in synthesis costs.
Scenario 2 – GMP‑Grade Clinical Supply
For a Phase I trial, a pharma partner required 250 g of a patented mitochondrial delivery vector. Our OEM service provided a fully validated batch, complete with FDA‑style CMC documentation, on schedule—allowing the trial to start on day 1 without regulatory delay.
Ready to accelerate your project? Request a free sample now.
For batches up to 10 g, we guarantee **7 business days** after final sequence approval. Larger scales (≥1 kg) are completed within **15 days** with priority shipping.
Yes. All clinical‑grade peptides are produced in our cGMP‑certified facilities, accompanied by a full CMC dossier, batch records, and certificates of analysis (COA).
Absolutely. Our in‑house peptide chemists collaborate with you to improve stability, cell‑penetration, and mitochondrial targeting efficiency, then scale the optimized sequence to production.
We offer DHL, FedEx, UPS (express) and sea‑freight for bulk orders. All shipments are temperature‑controlled (2‑8 °C) and fully customs‑cleared.

Every batch undergoes HPLC (>98.5% purity), LC‑MS, and NMR verification. We also provide functional assay data on request.
We accept T/T, L/C, PayPal Business, and major credit cards. For repeat customers, net‑30 or net‑60 terms can be negotiated after credit review.
Order a **free 100 mg sample** today and receive a **10% discount** on your first production batch (up to 5 kg). Offer valid for the next 7 days or until stock runs out.
“The fastest peptide supplier we’ve ever worked with. The 10 g batch arrived in 6 days, and the purity report was flawless.”
— Lisa M., Procurement Lead, Apex Therapeutics (USA)
“Their OEM design saved us 3 months of R&D. The mitochondrial targeting sequence we co‑developed showed a 42% increase in cellular uptake.”
— Dr. Ahmed Patel, Chief Scientist, MitoGen Labs (Canada)
“Transparent pricing and no hidden fees. We reduced our peptide budget by 20% while keeping quality at 99.8% purity.”
— Karen Liu, Operations Manager, BioFusion Inc. (USA)
Global Technology Co., Ltd – No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan Province, China.
Tel: +86 199 4383 0844 | Email: service@huanqiukeji9.com
Visit our Contact Page for a privacy‑policy statement and data‑protection details.
Trusted By Industry Leaders Worldwide
“Switching to Global Technology cut our peptide cost by 22% and reduced lead time from 6 weeks to 10 days. The QC reports are crystal‑clear, and the team’s technical support is outstanding.” – Dr. Emily Chen, Senior Director of R&D, NovaGen Biopharma (USA)
Antide-peptide-for-hormone-dependent-disease-models Best-Tirzepatide-Company-and-Supplier-Exporter CAS-440635-61-0-ADC-Linker Collagen-Induced-Arthritis-(CIA)-antigen
“Their OEM design service helped us redesign a mitochondrial targeting sequence that increased cellular uptake by 37% without additional synthesis steps.” – Mark Rivera, VP of Product Development, BioMitoch Ltd. (Canada)
Compliance & Certifications
View full certification library